✦ LIBER ✦

Carcinoma core distribution in patients with palpable and nonpalpable prostate tumors

✍ Scribed by Javier Hernandez; Ian M. Thompson

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 39 KB
Volume: 103
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Differences in tumor core distribution b

Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound-guided template prostate biopsy

✍ Takayoshi Demura; Takaya Hioka; Tsuyoshi Furuno; Tatsuo Kaneta; Hiroko Gotoda; S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Simultaneous determination of six tumor

Simultaneous determination of six tumor markers in patients with prostatic carcinoma and bladder tumors

✍ Schwemmer, B. ;Sch�tz, W. ;Kuntz, R.M. ;Lehmer, A. 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 352 KB

Potential benefit of improved local tumo

Potential benefit of improved local tumor control in patients with prostate carcinoma

✍ Deborah A. Kuban; Anas M. El-Mahdi; Paul F. Schellhammer 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 736 KB

Circulating neuroendocrine markers in pa

Circulating neuroendocrine markers in patients with prostate carcinoma

✍ Alfredo Berruti; Luigi Dogliotti; Alessandra Mosca; Maurizio Bellina; Mauro Mari 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Prognosis in patients with carcinoma of

Prognosis in patients with carcinoma of the prostate

✍ Joseph N. Corriere Jr.; John L. Cornog; John J. Murphy 📂 Article 📅 1970 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

Prostate specific antigen density in pat

Prostate specific antigen density in patients with histologically proven prostate carcinoma

✍ Mark Nishiya; Gary J. Miller; David H. Lookner; E. David Crawford 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 696 KB

Background. Prostate specific antigen (PSA) does not appear to have the specificity to distinguish between benign prostate hyperplasia and cancer when the PSA is low. PSA density is thought by many to improve the specificity for cancer; however, this theory remains controversial. Methods. The autho